Ozempic for Diabetes - Search News

Novo Nordisk’s Ozempic Gets FDA Approval

CNN on MSN · 1d

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with chronic kidney disease,

CNBC on MSN · 1d

FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves a gradual loss of kidney function.

Bloomberg on MSN · 20h

Novo’s Ozempic Gains US Nod for Kidney Disease, Widening Use

Novo Nordisk A/S’s blockbuster Ozempic won US approval to treat chronic kidney disease in patients who also have type 2 diabetes, further expanding the popular drug’s use.

1d

Ozempic vs. Semaglutide: 10 Weight Loss Medications Compared for 2025

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Inside Your Health: Ozempic and Zepbound

Both of these GLP-1 drugs were originally designed for diabetes, but their benefits keep expanding — KSTP health expert Dr.

16h

An Ozempic Expert Explains What You Need to Know Before Taking GLP-1 Drugs

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like ...

17h

Ozempic May Reduce Bone Density; Know Other Possible Side Effects

A healthy diet with regular exercise can help with sustainable weight loss. However, the use of Ozempic may contribute to ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results